NodThera is a biotechnology company focused on treating chronic diseases by targeting inflammation at its source. The company develops therapeutics that modulate inflammatory pathways to address diseases driven by inflammatory processes. Based in the United Kingdom, NodThera emphasizes immunology-driven drug discovery and translational research to bring targeted anti-inflammatory therapies to patients.
No recent deals for this company.